0001140361-18-016002.txt : 20180329 0001140361-18-016002.hdr.sgml : 20180329 20180329205047 ACCESSION NUMBER: 0001140361-18-016002 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180328 FILED AS OF DATE: 20180329 DATE AS OF CHANGE: 20180329 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MORE ROBERT J CENTRAL INDEX KEY: 0001207792 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38155 FILM NUMBER: 18724599 MAIL ADDRESS: STREET 1: 2285 W. WHITE PINE LANE CITY: PARK CITY STATE: UT ZIP: 84060 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Sienna Biopharmaceuticals, Inc. CENTRAL INDEX KEY: 0001656328 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 273364627 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 30699 RUSSELL RANCH ROAD, SUITE 140 CITY: WESTLAKE VILLAGE STATE: CA ZIP: 91362 BUSINESS PHONE: (818) 629-2256 MAIL ADDRESS: STREET 1: 30699 RUSSELL RANCH ROAD, SUITE 140 CITY: WESTLAKE VILLAGE STATE: CA ZIP: 91362 FORMER COMPANY: FORMER CONFORMED NAME: Sienna Labs, Inc. DATE OF NAME CHANGE: 20151020 4 1 doc1.xml FORM 4 X0306 4 2018-03-28 0 0001656328 Sienna Biopharmaceuticals, Inc. SNNA 0001207792 MORE ROBERT J C/O SIENNA BIOPHARMACEUTICALS, INC. 30699 RUSSELL RANCH ROAD, SUITE 140 WESTLAKE VILLAGE CA 91362 1 0 0 0 Common Stock 2018-03-28 4 S 0 10000 18.84 D 193249 D Common Stock 2018-03-29 4 S 0 14429 18.78 D 178820 D This transaction was executed in multiple trades in prices ranging from $18.8213 to $18.869, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. This transaction was executed in multiple trades in prices ranging from $18.75 to $18.99, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. /s/ Timothy K. Andrews, attorney-in-fact for Robert J. More 2018-03-29